GBT Reports Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall St futures mixed ahead of CPI, bank earnings; US-Iran tensions in focus
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Global Blood Therapeutics (GBT) Tops Q2 EPS by 7c
August 3, 2021 4:46 PM EDTGlobal Blood Therapeutics (NASDAQ: GBT) reported Q2 EPS of ($1.12), $0.07 better than the analyst estimate of ($1.19). Revenue for the quarter came in at $47.6 million versus the consensus estimate of $43.84 million.
For earnings history and earnings-related data on Global Blood Therapeutics (GBT) click here.
... More